Form 4 for ONC BeOne Medicines Ltd.
Accepted 2026-06-15 17:55:24 ET · period of report 2026-06-11 · accession 0002031182-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-15 17:55 | 2026-06-11 | ONC | Rosenberg Aaron | CFO | A - Grant | $0.00 | +71.2K | 397.9K | +22% | $0 |
| D | 2026-06-15 17:55 | 2026-06-11 | ONC | Rosenberg Aaron | CFO | S - Sale | $257.74 | -631 | 0 | -100% | -$162.6K |
| D | 2026-06-15 17:55 | 2026-06-11 | ONC | Rosenberg Aaron | CFO | A - Grant | $0.00 | +137.9K | 137.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-06-11 | A | A | 71,175 | $0.00 | 397,891 | D | — | — | (F1) Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 11, 2026, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. |
| 2 | Common | American Depositary Shares | 2026-06-11 | S | D | 631 | $257.74 | 0 | D | — | — | (F2) Each American Depositary Share represents 13 Ordinary Shares. (F3) The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.3392 to $257.765, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. |
| 3 | Derivative | Share Option (Right to Buy) | 2026-06-11 | A | A | 137,865 | $0.00 | 137,865 | D | $20.81 · — to 2036-06-10 | 137,865 Ordinary Shares | (F5) The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. (F5) The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. (F6) These securities vest over a four-year period as follows: 25% on the first anniversary of June 11, 2026 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. |